NBOMe Designer drug exposures reported to Texas poison centers

Journal of Addictive Diseases

Volumn 33, Issue 3, 2014, Pages 196-201

  Forrester, Mathias B ^a  

^a TEXAS DEPARTMENT OF STATE HEALTH SERVICES   (United States)

Author keywords

25C NBOMe; 25I NBOMe; Designer drug; NBOMe; Poison center

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTIEMETIC AGENT; ANTIHISTAMINIC AGENT; BENZODIAZEPINE; DESIGNER DRUG; INFUSION FLUID; NALOXONE; PHENETHYLAMINE DERIVATIVE; 2-(4-IODO-2,5-DIMETHOXYPHENYL)-N-(2-METHOXYBENZYL)ETHANAMINE; HOMOVERATRYLAMINE;

ADOLESCENT; ADULT; ARTICLE; CARDIOTOXICITY; DRUG EXPOSURE; DRUG INTOXICATION; FEMALE; HALLUCINATION; HEALTH SERVICE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC ACIDOSIS; MYDRIASIS; NEUROTOXICITY; POISON CENTER; RESUSCITATION; RHABDOMYOLYSIS; TACHYCARDIA; TELECONSULTATION; ANALOGS AND DERIVATIVES; SUBSTANCE-RELATED DISORDERS; UNITED STATES; UTILIZATION; YOUNG ADULT;

ADOLESCENT; ADULT; DESIGNER DRUGS; DIMETHOXYPHENYLETHYLAMINE; HUMANS; MALE; POISON CONTROL CENTERS; SUBSTANCE-RELATED DISORDERS; TEXAS; YOUNG ADULT;

EID: 84910616817     PISSN: 10550887     EISSN: 15450848     Source Type: Journal    
DOI: 10.1080/10550887.2014.950027     Document Type: Article

References (19)

1. Drug Enforcement Administration. Department of Justice. Schedules of controlled substances: temporary placement of three synthetic phenethylamines into Schedule I. Final order. Fed Regist 2013; 78:68716-9.
2. Harris County Institute of Forensic Sciences. Designer psychedelics: New class of designer drugs in Harris County. September 12, 2012.
3. Nikolaou P, Papoutsis I, Stefanidou M, Spiliopoulou C, Athanaselis S. 2C-I-NBOMe, an "N-bomb" that kills with "Smiles". Toxicological and legislative aspects. Drug Chem Toxicol 2014 [Epub ahead of print].
4. Drug Enforcement Administration. 25I-NBOMe, 25C-NBOMe, and 25B-NBOMe (Street names: N-bomb, Smiles, 25I, 25C, 25B). Springfield, VA: Drug Enforcement Administration, 2013.
5. Gonzalez-Maeso J, Weisstaub NV, Zhou M, et al. Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior. Neuron 2007; 53:439-52.
6. Halberstadt AL, Geyer MA. Effects of the hallucinogen 2,5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch response. Neuropharmacology 2014; 77:200-7.
7. Advisory Council on the Misuse of Drugs. 'NBOMe' compounds: A review of the evidence of use and harm. London, England; May 29, 2013:10-16. https://www.gov.uk/government/uploads/system/uploads/attachment-data/file/261786/NBOMe-compounds-report.pdf (Accessed September 17, 2014).
8. Ninnemann A, Stuart GL. The NBOMe series: a novel, dangerous group of hallucinogenic drugs. J Stud Alcohol Drugs 2013; 74:977-8.
9. Kelly A, Eisenga B, Riley B, Judge B. Case series of 25I-NBOMe exposures with laboratory confirmation. Clin Toxicol (Phila) 2012; 50:702.
10. Hassan A. Lethal designer drug taking lives in streets of Houston. Houston Chronicle September 23, 2012; 111(346):B1, B4.
11. Rose RS, Cumpston KL, Stromberg PE, Wills BK. Severe poisoning following self-reported use of 25-I, a novel substituted amphetamine. Clin Toxicol (Phila) 2012; 50:707-8.
12. Caldicott DG, Bright SJ, Barratt MJ. NBOMe - a very different kettle of fish. Med J Aust 2013; 199:322-3.
13. Hill SL, Doris T, Gurung S, et al. Severe clinical toxicity associated with analytically confirmed recreational use of 25I-NBOMe: case series. Clin Toxicol (Phila) 2013;51:487-92.
14. Poklis JL, Nanco CR, Troendle MM, Wolf CE, Poklis A. Determination of 4-bromo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]- benzeneethanamine (25B-NBOMe) in serum and urine by high performance liquid chromatography with tandem mass spectrometry in a case of severe intoxication. Drug Test Anal 2013; 6:764-9.
15. Poklis JL, Devers KG, Arbefeville EF, Pearson JM, Houston E, Poklis A. Postmortem detection of 25I-NBOMe [2-(4-iodo-2,5- dimethoxyphenyl)-N-[(2-methoxyphenyl) methyl]ethanamine] in fluids and tissues determined by high performance liquid chromatography with tandem mass spectrometry from a traumatic death. Forensic Sci Int 2014; 234:e14-20. doi: 10.1016/j.forsciint.2013.10.015.
16. Rose RS, Poklis JL, Poklis A. A case of 25INBOMe (25-I) intoxication: a new potent 5-HT2A agonist designer drug. Clin Toxicol (Phila) 2013; 51:174-7.
17. Stellpflug SJ, Kealey SE, Hegarty CB, Janis GC. 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25INBOMe): clinical case with unique confirmatory testing. J Med Toxicol 2014; 10:45-50. doi: 10.1007/s13181-013-0314-y.
18. Mowry JB, Spyker DA, Cantilena LR Jr, Bailey JE, Ford M. 2012 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 30th Annual Report. Clin Toxicol (Phila) 2013; 51:949-1229. doi: 10.3109/15563650.2013.863906.
19. Forrester MB. 2C series phenethylamine derivative exposures in Texas. Subst Abus 2013; 34:81-2. doi: 10.1080/08897077.2012.715623.